1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Substance Abuse Deterrents and Treatments - An Assessment of the Technological, Competitive and R&D Landscape

Substance Abuse Deterrents and Treatments - An Assessment of the Technological, Competitive and R&D Landscape

Summary

GBI Research's latest report, "Substance Abuse Deterrents and Treatments - An Assessment of the Technological, Competitive and R&D Landscape", discusses global trends in the substance abuse deterrents and addiction treatments market including the impact substance abuse is having on local economies, healthcare systems and society as a whole. This new report provides analyses of current unmet medical needs as well as an in-depth review and assessment of technologies being employed by pharmaceutical manufacturers to reduce the risk of prescription drug misuse and abuse. A series of detailed case studies showcase novel abuse deterrent formulations (ADFs) that have been recently adopted by manufacturers of commonly abused prescription drugs. Although these technologies are relatively nascent, we expect the ADF field to grow rapidly in the coming years driven by strong demand and local government support within many key markets.

Information leveraged from our robust industry-leading database shows a diverse range of drug therapies currently in development for the treatment of substance abuse and addiction, with various novel approaches under investigation. Our new study provides multilevel analysis of both the R&D and marketed product landscape including data and analyses by addiction type, molecule, stage of development, route of administration, company, geographical presence and many other insightful and pertinent analytics. Additionally, the report includes our predictions on the future treatment landscape.

GBI Research conducted extensive research efforts in order to provide a comprehensive view of the technological, competitive and R&D landscape of the substance abuse deterrents and treatments market. This new report adds to our unique portfolio of trusted industry analyses that enable our clients to assess the most promising commercial areas in the market and exploit key business opportunities.

Scope

- How does substance abuse impact individuals, society, the economy and healthcare systems?
- What are the most pertinent commercial trends in the substance abuse deterrents and treatments market?
- What are the most pressing medical needs yet to be addressed regarding substance abuse and addiction?
- What are the most recent advances in abuse deterrent formulation technology?

Marketed products for the treatment of substance abuse and addiction

- What are the products with the highest degree of commercialization?
- What are the indications with the highest volume of marketed products?
- What are the main segments of interest for companies operating in the substance abuse treatments market?
- Who are the leading companies, with the highest volume of products in the market and with the widest geographical presence?
- What are the most prevalent routes of administration of products in the market?

Pipeline therapies for the treatment of substance abuse and addiction

- What role are universities and research institutions playing in the development of novel therapies?
- What indications have the largest number of therapies in development?
- Which companies have the largest portfolios of therapies in development?
- Which therapies are expected to treat multiple indications?
- In which stage of development are most of the pipeline therapies currently concentrated?
- Which types of molecules and routes of administration currently dominate the substance abuse therapies pipeline?
- How will the product and competitive landscape be redefined by the expected launch of novel therapies in the coming years?

Key Reasons to Purchase

This report will allow you to

- Gain insightful analyses and understanding of market dynamics: This report comprehensively describes and assesses the most pertinent commercial, technological, and innovative aspects of the substance abuse deterrents and treatments market.
- Assess marketed and pipeline products for treating substance abuse and addiction: Our new study provides multilevel analyses of the key products currently available for treating various substance abuse addictions as well as promising candidates currently in development.
- Understand current unmet medical needs: This report provides insights regarding the impact substance abuse can have on individuals and society as whole as well as an in-depth gap analysis that helps to identify to the most pressing medical needs yet to be addressed.
- Assess advances in drug deterrent technology, their advantages and their limitations: This report assesses current and novel formulation strategies being implemented by drug manufacturers to reduce the risk of prescription misuse and abuse. Analyses include key advantages, limitations as well as arguments for and against their adoption.
- Assess global trends prevailing in the field of substance abuse deterrents and treatments: This report describes trends at a global level regarding drug use prevalence, regulations and guidelines, as well as the different approaches being taken in different countries to tackle this global issue.

Table Of Contents

Substance Abuse Deterrents and Treatments - An Assessment of the Technological, Competitive and RandD Landscape
Table Of Contents
Introduction
Overview: Substance Abuse, Deterrence and Treatments
Contributing Factors of Drug Abuse and Addiction
Commonly Abused Substances
Prescription or OTC Substance Abuse
Common Effects and Symptoms of Substance Abuse
Substance Abuse and Brain Function
Health, Social and Economic Impact of Substance Abuse
Impact of Substance Abuse on Specific Population Groups
Substance Abuse: Global Trends and Regulatory Developments
Illicit Substance Abuse: Global Trends
Trends in Global Number of Abusers of Illicit Drugs
Global Trends in Alcohol and Nicotine Use and Addiction
Global Trends in Injecting Drug Use and HIV Infection
International Guidelines Developed by the UN for Abusable Substances
The Role of the International Narcotics Control Board in Controlling Substance Abuse
Worldwide Differences in Regulations and Approaches to Tackle Substance Abuse
Unmet Medical Need Analysis and Gaps in the Treatment of Substance abuse
Technologies for Developing Abuse Deterrent Products
Abuse Deterrent Formulation Technologies: Key Advantages
Limitations of Abuse Deterrent Formulations and Arguments Against Adoption
Abuse Deterrent Formulation Strategies
Case Studies
Embeda
Suboxone
INTAC technology
DETERx technology
Osmotic extended-release oral delivery system
Aversion Technology
iCRT-deter
Prodrug Combined with MPAR Technology
Marketed Products For the Treatment of Substance Abuse
Marketed Therapies by Type of Addiction
Volume of Companies Operating in the Substance Abuse Treatment Market by Type of Addiction
Substance Abuse Therapies with Highest Degree of Commercialization
Companies with Highest Volume of Marketed Therapies for Substance Abuse
Key Companies with a Wide Global Presence
Competitive and Product Landscape Analysis in Key Countries
Lists of Key Marketed Products by Type of Addiction
Key Routes of Administration of Marketed Products by Type of Addiction
Pipeline Products For the Treatment of Substance Abuse
Volume of Pipeline Therapies by Type of Organization
Volume of Pipeline Therapies by Type of Addiction
Organizations with the Highest Volume of Pipeline Therapies
Volume of Pipeline Therapies by Stage of Development
Profiles of Late Stage Pipeline Products
Volume of Pipeline Therapies by Type of Molecule and Route of Administration
Future Treatment Landscape
Bibliography

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Major Depressive Disorder - Global Drug Forecast and Market Assessment to 2025

PharmaPoint: Major Depressive Disorder - Global Drug Forecast and Market Assessment to 2025

  • $ 10995
  • Industry report
  • October 2016
  • by Global Data

PharmaPoint: Major Depressive Disorder - Global Drug Forecast and Market Assessment to 2025 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. It is characterized ...

Colorectal Cancer KOL Insight 2016

Colorectal Cancer KOL Insight 2016

  • $ 8085
  • Industry report
  • October 2016
  • by Firstword Pharma

KOLs embrace novel MoAs as low survival rates drive search for new treatments Faced with persistently low survival rates, KOLs are calling for new approaches to treat late-stage colorectal cancer (CRC). ...

Frontier Pharma: Hepatitis C - Diverse Range of First-in-Class Host-Targeting and Direct-Acting Antivirals Offer Potential in Difficult-to-Treat Populations

Frontier Pharma: Hepatitis C - Diverse Range of First-in-Class Host-Targeting and Direct-Acting Antivirals Offer Potential in Difficult-to-Treat Populations

  • $ 6995
  • Industry report
  • December 2016
  • by GBI Research

Frontier Pharma: Hepatitis C - Diverse Range of First-in-Class Host-Targeting and Direct-Acting Antivirals Offer Potential in Difficult-to-Treat Populations Summary Hepatitis C is a blood-borne viral infection ...


Download Unlimited Documents from Trusted Public Sources

Biological Therapy Industry in the US

  • January 2017
    9 pages
  • Vaccine  

  • United States  

View report >

Therapy Market in the UK

  • January 2017
    19 pages
  • Therapy  

  • United Kingdom  

View report >

Global Therapy Market

  • January 2017
    32 pages
  • Therapy  

    Targeted Therap...  

    Monoclonal Anti...  

  • World  

View report >

Related Market Segments :

Therapy

ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.